KOBV Portal

Hits per page

hit 1 - 1 | 1 hit

Select All Export

Online Resource

Clinical activity and tolerability of enzalutamide (MDV3100) in patients with metastatic, castration‐resistant prostate cancer who progress after docetaxel and abiraterone treatment

Badrising, Sushil ; van der Noort, Vincent ; van Oort, Inge M. ; [et al.]

Wiley ; 2014

In: Cancer Vol. 120, No. 7 ( 2014-04), p. 968-975

add to watchlist on the watchlist

Details

In: Cancer, Wiley, Vol. 120, No. 7 ( 2014-04), p. 968-975

Abstract: Enzalutamide has modest clinical activity in patients with metastatic, castration‐resistant prostate cancer who received previous treatment with docetaxel and abiraterone. Prostate‐specific antigen response to docetaxel and abiraterone does not predict for prostate‐specific antigen response to enzalutamide.

Type of Medium: Online Resource

ISSN: 0008-543X , 1097-0142

URL: Issue

URL: Article

DOI: 10.1002/cncr.v120.7

DOI: 10.1002/cncr.28518

Language: English

Publisher: Wiley

Publication Date: 2014

detail.hit.zdb_id: 1479932-7

detail.hit.zdb_id: 2599218-1

detail.hit.zdb_id: 2594979-2